These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 17517629

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
    Evangelisti C, de Biase D, Kurelac I, Ceccarelli C, Prokisch H, Meitinger T, Caria P, Vanni R, Romeo G, Tallini G, Gasparre G, Bonora E.
    BMC Cancer; 2015 Mar 21; 15():157. PubMed ID: 25880213
    [Abstract] [Full Text] [Related]

  • 3. Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations.
    Corver WE, van Wezel T, Molenaar K, Schrumpf M, van den Akker B, van Eijk R, Ruano Neto D, Oosting J, Morreau H.
    Genes Chromosomes Cancer; 2014 Oct 21; 53(10):833-44. PubMed ID: 24909752
    [Abstract] [Full Text] [Related]

  • 4. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
    Dettori T, Frau DV, Lai ML, Mariotti S, Uccheddu A, Daniele GM, Tallini G, Faa G, Vanni R.
    Genes Chromosomes Cancer; 2003 Sep 21; 38(1):22-31. PubMed ID: 12874783
    [Abstract] [Full Text] [Related]

  • 5. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
    Bonora E, Porcelli AM, Gasparre G, Biondi A, Ghelli A, Carelli V, Baracca A, Tallini G, Martinuzzi A, Lenaz G, Rugolo M, Romeo G.
    Cancer Res; 2006 Jun 15; 66(12):6087-96. PubMed ID: 16778181
    [Abstract] [Full Text] [Related]

  • 6. Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.
    Cavadas B, Pereira JB, Correia M, Fernandes V, Eloy C, Sobrinho-Simões M, Soares P, Samuels DC, Máximo V, Pereira L.
    Mitochondrion; 2019 May 15; 46():123-133. PubMed ID: 29631022
    [Abstract] [Full Text] [Related]

  • 7. Oncocytic tumors are marked by enhanced mitochondrial content and mtDNA mutations of complex I in Chinese patients.
    Lyu L, Wang Q, Song S, Li L, Zhou H, Li M, Jiang Z, Zhou C, Chen G, Lyu J, Bai Y.
    Mitochondrion; 2019 Mar 15; 45():1-6. PubMed ID: 29386142
    [Abstract] [Full Text] [Related]

  • 8. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O, De Luise M, de Biase D, Caporali L, Fiorini C, Gasparre G, Carelli V, Hackl D, Imamovic L, Haim S, Sobrinho-Simões M, Tallini G.
    J Pathol Clin Res; 2022 Mar 15; 8(2):155-168. PubMed ID: 34792302
    [Abstract] [Full Text] [Related]

  • 9. Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.
    Pereira L, Soares P, Máximo V, Samuels DC.
    BMC Cancer; 2012 Feb 02; 12():53. PubMed ID: 22299657
    [Abstract] [Full Text] [Related]

  • 10. An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells.
    Gasparre G, Iommarini L, Porcelli AM, Lang M, Ferri GG, Kurelac I, Zuntini R, Mariani E, Pennisi LF, Pasquini E, Pasquinelli G, Ghelli A, Bonora E, Ceccarelli C, Rugolo M, Salfi N, Romeo G, Carelli V.
    Hum Mutat; 2009 Mar 02; 30(3):391-6. PubMed ID: 19086058
    [Abstract] [Full Text] [Related]

  • 11. Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.
    Kurelac I, MacKay A, Lambros MB, Di Cesare E, Cenacchi G, Ceccarelli C, Morra I, Melcarne A, Morandi L, Calabrese FM, Attimonelli M, Tallini G, Reis-Filho JS, Gasparre G.
    Hum Mol Genet; 2013 Jan 15; 22(2):226-38. PubMed ID: 23049073
    [Abstract] [Full Text] [Related]

  • 12. Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference?
    Tsybrovskyy O, Rössmann-Tsybrovskyy M.
    Histopathology; 2009 Dec 15; 55(6):665-82. PubMed ID: 20002768
    [Abstract] [Full Text] [Related]

  • 13. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
    Máximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simões M.
    Am J Pathol; 2002 May 15; 160(5):1857-65. PubMed ID: 12000737
    [Abstract] [Full Text] [Related]

  • 14. Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.
    Conti L, Vatrano S, Bertero L, Masu L, Pacchioni D, Daniele L, De Rosa G, Cassoni P, Volante M, Papotti M.
    Hum Pathol; 2017 Nov 15; 69():23-30. PubMed ID: 28962946
    [Abstract] [Full Text] [Related]

  • 15. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
    Abu-Amero KK, Alzahrani AS, Zou M, Shi Y.
    Oncogene; 2005 Feb 17; 24(8):1455-60. PubMed ID: 15608681
    [Abstract] [Full Text] [Related]

  • 16. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.
    Yeh JJ, Lunetta KL, van Orsouw NJ, Moore FD, Mutter GL, Vijg J, Dahia PL, Eng C.
    Oncogene; 2000 Apr 13; 19(16):2060-6. PubMed ID: 10803467
    [Abstract] [Full Text] [Related]

  • 17. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors.
    Mussazhanova Z, Shimamura M, Kurashige T, Ito M, Nakashima M, Nagayama Y.
    Cancer Sci; 2020 Aug 13; 111(8):2814-2823. PubMed ID: 32458504
    [Abstract] [Full Text] [Related]

  • 18. Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors.
    Zhang J, Yu W, Ryu SW, Lin J, Buentello G, Tibshirani R, Suliburk J, Eberlin LS.
    Cancer Res; 2016 Nov 15; 76(22):6588-6597. PubMed ID: 27659048
    [Abstract] [Full Text] [Related]

  • 19. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors.
    Tallini G, Ladanyi M, Rosai J, Jhanwar SC.
    Cytogenet Cell Genet; 1994 Nov 15; 66(4):253-9. PubMed ID: 7909283
    [Abstract] [Full Text] [Related]

  • 20. Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.
    Mete O, Asa SL.
    Endocr Pathol; 2010 Mar 15; 21(1):16-24. PubMed ID: 20013317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.